Free Equity Delivery
Flat ₹10 per Trade in Intraday & F&O
Ganga Pharmaceuticals IPO is a fixed price issue of ₹1.54 crores. The issue is entirely a fresh issue of 0.10 crore shares of ₹1.54 crore.
Ganga Pharmaceuticals IPO bidding started from Jan 29, 2016 and ended on Feb 9, 2016. The shares got listed on BSE SME on Feb 22, 2016.
Ganga Pharmaceuticals IPO price is ₹15.00 per share . The lot size for an application is 8,000. The minimum amount of investment required by an individual investor (retail) is ₹1,20,000 (8000 shares). The minimum lot size investment for HNI is 2 lots (16,000 shares), amounting to ₹2,40,000.
First Overseas Capital Ltd. is the book running lead manager and Kfin Technologies Ltd. is the registrar of the issue. The market maker of the company is Alacrity Securities Ltd..
Refer to Ganga Pharmaceuticals IPO RHP for detailed Information.
| IPO Date | January 29, 2016 to February 9, 2016 |
| Listing Date | February 22, 2016 |
| Face Value | ₹10 per share |
| Issue Price Band | |
| Issue Price Final | ₹15 per share |
| Lot Size | 8,000 Shares |
| Sale Type | Fresh Capital |
| Total Issue Size | 10,24,000 shares (aggregating up to ₹1.54 Cr) |
| Issue Type | Fixed Price IPO |
| Listing At | BSE SME |
| Share Holding Pre Issue | 30,37,500 shares |
| Share Holding Post Issue | 4,06,15,000 shares |
Ganga Pharmaceuticals IPO offers total 10,24,000 shares. Out of which 5,12,000 (50.00%) allocated to NII, 5,12,000 (50.00%) allocated to RII.
| Investor Category | Shares Offered |
|---|---|
| NII (HNI) Shares Offered | 5,12,000 (50.00%) |
| Retail Shares Offered | 5,12,000 (50.00%) |
| Total Shares Offered | 10,24,000 (100.00%) |
Ganga Pharmaceuticals IPO opens on January 29, 2016, and closes on February 9, 2016.
| IPO Open Date | Fri, Jan 29, 2016 |
| IPO Close Date | Tue, Feb 9, 2016 |
| Tentative Listing Date | Mon, Feb 22, 2016 |
| Cut-off time for UPI mandate confirmation | 5 PM on Tue, Feb 9, 2016 |
Investors can bid for a minimum of 8,000 shares and in multiples thereof. The following table depicts the minimum and maximum investment by Individual Investors (Retail) and HNI in terms of shares and amount.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 8,000 | ₹1,20,000 |
| Retail (Max) | 1 | 8,000 | ₹1,20,000 |
| HNI (Min) | 2 | 16,000 | ₹2,40,000 |
Note : The value will be calculated using Equity Dilution = Share Holding Pre Issue - Share Holding Post Issue
Incorporated in 1994, Ganga Pharmaceuticals Ltd (GPL) is engaged in production of quality Bulk Ayurvedic Medicines in Mumbai. Apart from manufacturing, the company is also into marketing, distribution of Bulk Ayurvedic Medicines all over Maharashtra.
Company is manufacturing the following proprietary products:
1) Ampachan Vati;
2) Khadira Vati;
3) Nirmalaya churna
Company's products are available in liquid dosage form and solid dosage forms. Liquid dosage form includes Oil-based products and solid dosage forms includes Powder-based products, Tablets, and Pills.
The Company Ganga Pharmaceuticals IPO proposes to utilise the Net Proceeds from the Issue towards the following objects:
| S.No. | Objects of the Issue | Expected Amount (₹ in crores) |
|---|---|---|
| 1 | Deployment of production capacity | 0.25 |
| 2 | Marketing and Brand Building | 0.70 |
| 3 | General Corporate Purpose | 0.30 |
| 4 | Issue Expenses | 0.29 |
[Dilip Davda] <p><strong>Issue is aggressively priced. Only risk savvy investors may consider investment for long term.</strong></p> Read detail review...
| Listing Date | February 22, 2016 |
| BSE Script Code | 539680 |
| NSE Symbol | |
| ISIN | INE615T01017 |
| Final Issue Price | ₹15 per share |
| BSE Listing Group | MT |
| Price Details | BSE SME |
|---|---|
| Final Issue Price | ₹15.00 |
| Open | ₹14.50 |
| Low | ₹14.50 |
| High | ₹14.50 |
| Last Trade | ₹14.50 |
Ganga Pharmaceuticals Ltd.
1 - A, 802,
N.G. Suncity Ph II,
Kandivali East,
Mumbai, Maharashtra, 400101
Phone: +91 250 609 8333/444
Email: ayurvedganga@gmail.com
Website: http://www.ayurvedganga.com
Kfin Technologies Ltd.
Phone: 04067162222, 04079611000
Email: einward.ris@karvy.com
Website: https://ipostatus.kfintech.com/
Ganga Pharmaceuticals IPO is a SME IPO of 10,24,000 equity shares of the face value of ₹10 aggregating up to ₹1.54 Crores. The issue is priced at ₹15 per share. The minimum order quantity is 8000.
The IPO opens on January 29, 2016, and closes on February 9, 2016.
Kfin Technologies Ltd. is the registrar for the IPO. The shares are proposed to be listed on BSE SME.
Zerodha customers can apply online in Ganga Pharmaceuticals IPO using UPI as a payment gateway. Zerodha customers can apply in Ganga Pharmaceuticals IPO by login into Zerodha Console (back office) and submitting an IPO application form.
Steps to apply in Ganga Pharmaceuticals IPO through Zerodha
Visit Zerodha IPO Application Process Review for more detail.
The Ganga Pharmaceuticals IPO opens on January 29, 2016 and closes on February 9, 2016.
Ganga Pharmaceuticals IPO lot size is 8000, and the minimum amount required for application is ₹1,20,000.
You can apply in Ganga Pharmaceuticals IPO online using either UPI or ASBA as a payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO Application is offered by brokers who don't offer banking services. Read more detail about applying IPO online through Zerodha, Upstox, 5Paisa, Nuvama, HDFC Bank, and SBI Bank.
The finalization of Basis of Allotment for Ganga Pharmaceuticals IPO will be done on [.], and the allotted shares will be credited to your demat account by [.]. Check the Ganga Pharmaceuticals IPO allotment status.
The Ganga Pharmaceuticals IPO listing date is on Monday, February 22, 2016.
Useful Articles
RHP